Table 1 Demographic and clinical characteristics of the patients
Conventional | ERAS | p | ||||
|---|---|---|---|---|---|---|
Mean | n | Mean | n | |||
Age | 63.37 ± 7.01 | 66.36 ± 5.31 | 0.080 | |||
Comorbidity | CCMI < 4 | 16 (33.3%) | 6 (27.3%) | 0.414 | ||
CCMI ≥ 4 | 32 (66.7%) | 16 (72.7%) | ||||
Preoperative PSA (ng/L) | 10.79 ± 5.57 | 9.73 ± 5.42 | 0.457 | |||
Digital rectal examination findings | No | 20 (41.7%) | 10 (45.5%) | 0.483 | ||
Yes | 28 (58.3%) | 12 (54.5%) | ||||
Extraprostatic involvement in preoperative imaging | Not view | 2 (4.2%) | 0 (0%) | 0.557 | ||
No | 40 (83.3%) | 20 (90.9%) | ||||
Yes | 6 (12.3%) | 2 (9.1%) | ||||
Lymph node status | Not viewed | 2 (4.2%) | 0 (0%) | 0.459 | ||
Absent | 44 (91.7%) | 20 (90.9%) | ||||
Present | 2 (4.2%) | 2 (9.1%) | ||||
Transrectal biopsy specimen Gleason score | Gleason = 6 | 20 (41.7%) | 10 (45.5%) | 0.206 | ||
Gleason = 7 | 14 (29.2%) | 10 (45.5%) | ||||
Gleason = 8 | 8 (16.7%) | 2 (9.1%) | ||||
Gleason > 8 | 6 (12.5%) | 0 (0%) | ||||
Location of tumor | Right | 6 (12.5%) | 4 (18.2%) | 0.806 | ||
Left | 4 (8.3%) | 2 (9.1%) | ||||
Bilateral | 38 (79.2%) | 16 (72.7%) | ||||
Time between biopsy and surgery (days) | 70.67 ± 21.19 | 71.36 ± 21.07 | 0.899 | |||
Lymphadenectomy status | Not done | 32 (66.7%) | 18 (81.8%) | 0.154 | ||
Done | 16 (33.3%) | 4 (18.2%) | ||||
Radical prostatectomy specimen Gleason score | Gleason = 6 | 12 (25%) | 2 (9.1%) | 0.089 | ||
Gleason = 7 | 12 (25%) | 10 (45.5%) | ||||
Gleason = 8 | 12 (25%) | 8 (36.4%) | ||||
Gleason > 8 | 12 (25%) | 2 (9.1%) | ||||